相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Case Report: Complete and Fast Recovery From Severe COVID-19 in a Pemphigus Patient Treated With Rituximab
Jo Linda Sinagra et al.
FRONTIERS IN IMMUNOLOGY (2021)
Immunophenotyping in pemphigus reveals a TH17/TFH17 cell-dominated immune response promoting desmoglein 1/3-specific autoantibody production
Julia Holstein et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Targeting interleukin 4 receptor α: A new approach to the treatment of cutaneous autoimmune bullous diseases?
Roberto Russo et al.
DERMATOLOGIC THERAPY (2020)
Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case series
Rana Abdat et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Mechanisms of skin autoimmunity: Cellular and soluble immune components of the skin
Johann E. Gudjonsson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Pemphigus
Michael Kasperkiewicz et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
HISAT: a fast spliced aligner with low memory requirements
Daehwan Kim et al.
NATURE METHODS (2015)
Pathogenic IgG Antibodies against Desmoglein 3 in Pemphigus Vulgaris Are Regulated by HLA-DRB1*04:02-Restricted T Cells
Ruediger Eming et al.
JOURNAL OF IMMUNOLOGY (2014)
Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3
Angela Nagel et al.
CLINICAL IMMUNOLOGY (2010)
A Single Helper T Cell Clone Is Sufficient to Commit Polyclonal Naive B Cells to Produce Pathogenic IgG in Experimental Pemphigus Vulgaris
Hayato Takahashi et al.
JOURNAL OF IMMUNOLOGY (2009)
Reliability and Convergent Validity of Two Outcome Instruments for Pemphigus
Misha Rosenbach et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles
C Veldman et al.
JOURNAL OF IMMUNOLOGY (2003)
分享论文
